Article ; Online: Nicotinamide drives T cell activation in the mammary tumor microenvironment
Journal of Translational Medicine, Vol 20, Iss 1, Pp 1-
2022 Volume 3
Abstract: Abstract Nicotinamide (NAM, a variant of vitamin B3) has recently been shown to accelerate the activation of human CD4+ and CD8+ T cells exposed to repeated CD3/CD28 agonism in vitro. Here, we demonstrate that T cells infiltrating mouse mammary ... ...
Abstract | Abstract Nicotinamide (NAM, a variant of vitamin B3) has recently been shown to accelerate the activation of human CD4+ and CD8+ T cells exposed to repeated CD3/CD28 agonism in vitro. Here, we demonstrate that T cells infiltrating mouse mammary carcinomas that are therapeutically controlled by NAM also express multiple markers of late-stage activation. Taken together, these findings lend additional support to the notion that the antineoplastic effects of NAM involve at least some degree of restored cancer immunosurveillance. |
---|---|
Keywords | CTLA4 ; Immune checkpoint inhibitors ; Immunotherapy ; PD-1 ; LAG3 ; TIM-3 ; Medicine ; R |
Language | English |
Publishing date | 2022-06-01T00:00:00Z |
Publisher | BMC |
Document type | Article ; Online |
Database | BASE - Bielefeld Academic Search Engine (life sciences selection) |
Full text online
More links
Kategorien
Inter-library loan at ZB MED
Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.